Spinal Fusion — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Spinal fusion is a surgical procedure that permanently joins two or more vertebrae together by creating bone bridges across the intervertebral disc spaces and/or posterior elements, eliminating motion at the fused segment and stabilising a painful or unstable spinal level. The procedure uses titanium pedicle screws and connecting rods to provide rigid internal fixation, combined with bone graft (autologous iliac crest, allograft, synthetic substitutes, or biologics such as rhBMP-2) placed in or around the disc space and decorticated bone surfaces to stimulate new bone formation and achieve solid fusion.

Multiple surgical approaches are used depending on the target level, pathology, and surgeon preference: posterior lumbar interbody fusion (PLIF) — a posterior approach with bilateral nerve root retraction to access the disc; transforaminal lumbar interbody fusion (TLIF) — a posterolateral approach through the foramen, widely favoured for its reduced nerve manipulation; anterior lumbar interbody fusion (ALIF) — access through the abdomen avoiding posterior scar; lateral lumbar interbody fusion (LLIF/XLIF/DLIF) — access through the flank lying on one's side, allowing large implant placement without posterior exposure; and cervical fusion (ACDF — anterior cervical discectomy and fusion) for neck disc disease.

Spinal fusion is one of the most commonly performed spinal operations worldwide, with more than 450,000 procedures annually in the United States alone. The number of fusion procedures has increased 7-fold over the past two decades, driven by improved implants, expanding indications, and an ageing population with degenerative spinal disease.

Spinal fusion is indicated when spinal instability, deformity, or degenerative disease causes symptoms that significantly impair quality of life and have not improved with at least 6–12 weeks of structured conservative management (physiotherapy, analgesic optimisation, steroid injections).

Common indications include: degenerative spondylolisthesis with neurogenic claudication (slippage of one vertebra over another causing canal stenosis and leg pain on walking); spinal instability from spondylolysis or isthmic spondylolisthesis (stress fracture of the pars interarticularis); adult spinal deformity including degenerative scoliosis causing trunk imbalance, pain, and claudication; recurrent disc herniation after discectomy where the disc space is collapsed; post-discectomy instability; spinal tumours requiring decompression and reconstruction; spinal trauma (fractures requiring stabilisation); and cervical myelopathy or radiculopathy from disc herniation or osteophyte causing arm weakness, numbness, or gait disturbance (ACDF).

The SPORT trial (Spine Patient Outcomes Research Trial) demonstrated that for degenerative spondylolisthesis, fusion plus decompression produced significantly better outcomes than decompression alone or non-operative management in patients with appropriate symptom severity.

All spinal fusion procedures are performed under general anaesthesia with continuous intraoperative neuromonitoring (IONM) — SSEPs, MEPs, and EMG — to detect and prevent neurological injury during dissection and implant placement.

TLIF procedure (most common single-level lumbar fusion approach): Patient prone on a Jackson table or padded frame. Midline posterior incision. Paraspinal muscles are elevated subperiosteally. Pedicle screws are placed bilaterally at both levels under fluoroscopic or CT navigation guidance. The facet joint on one side is removed (facetectomy), providing access to the intervertebral foramen. The disc is entered, endplates are prepared with curettes, and a trial sizer confirms implant dimensions. A banana-shaped PEEK (polyetheretherketone) or titanium interbody cage packed with bone graft is inserted into the disc space, restoring disc height, correcting sagittal alignment, and providing an anterior fusion surface. Rods are connected to the pedicle screws and tightened, compressing the segment. Additional bone graft is placed over the decorticated transverse processes and laminae (posterolateral fusion). Wounds are closed in layers; drain inserted.

Minimally invasive TLIF (MIS-TLIF) uses expandable tubular retractors through 2 cm incisions to place percutaneous pedicle screws with reduced muscle dissection, blood loss, and post-operative pain, enabling faster recovery. ALIF requires a separate vascular surgery or access surgery team to retract the aorta and iliac vessels safely for anterior disc access.

70–80% of patients achieve satisfactory pain relief and significant functional improvement at 2-year follow-up. The SPORT trial — the largest randomised trial of spinal surgery — showed that for degenerative spondylolisthesis, fusion achieved significantly better Oswestry Disability Index (ODI) and SF-36 physical function scores than non-operative management at 2 and 4 years, with the surgical benefit maintained at 8-year follow-up.

Neurogenic claudication (leg pain and weakness on walking) resolves or significantly improves in 75–85% of patients after decompression with fusion, restoring walking tolerance and daily activity. Radicular pain from nerve root compression resolves in 70–80%. Spinal alignment correction in adult deformity surgery significantly improves sagittal balance, reducing chronic low back pain from sagittal malalignment.

For cervical myelopathy from disc-osteophyte complex, ACDF achieves neurological improvement in 70–80% of patients and prevents progressive cord damage. Solid fusion provides durable stability — unlike motion preservation devices — with 10- and 15-year outcomes data confirming maintained function in appropriately selected patients. Economic analyses demonstrate that spinal fusion is cost-effective for properly selected patients with 2–3 years of cost recovery compared to continued medical management and disability.

Adjacent segment disease (ASD) — accelerated degeneration of the disc and facet joints immediately above or below the fused segment due to increased mechanical stress transfer — occurs in 5–10% at 10 years and is the most important long-term complication, potentially requiring extension of the fusion.

Pseudarthrosis (non-union, failure of bone bridging) occurs in 5–15% of single-level fusions, higher in smokers (nicotine profoundly inhibits bone healing), diabetics, patients with osteoporosis, and multi-level fusions. Symptomatic pseudarthrosis requires revision surgery with additional bone graft and instrumentation.

Pedicle screw malposition causing neural or vascular injury occurs in approximately 1–2%; IONM and navigation significantly reduce this risk. Neurological deterioration (dural tear causing CSF leak, nerve root injury causing new deficit) occurs in 1–3%. Surgical site infection — superficial (2–4%) or deep (1–2%) — may require irrigation and debridement. Blood loss requiring transfusion occurs in 20–40% of multi-level cases. Venous thromboembolism (DVT/PE) risk is 1–3% despite pharmacological and mechanical prophylaxis.

Walking with physiotherapy support begins the day after surgery, and most patients are mobilised to a chair on day 1. Hospital stay is typically 2–5 days for single-level TLIF; longer (5–10 days) for multi-level or revision fusions. A lumbar brace is worn for 6–12 weeks to protect the fusion while bone consolidation begins, particularly for patients with poor bone quality or multi-level constructs.

Post-operative pain management uses a multimodal approach: regular paracetamol and NSAIDs (NSAIDs must be used cautiously as they may impair bone healing — duration is typically limited to 4–6 weeks maximum), opioids on a weaning schedule, and regional nerve blocks when applicable. Epidural anaesthesia is not standard for posterior spinal fusion.

Return to sedentary work (desk-based) occurs at 4–8 weeks; manual or physically demanding work requires 3–6 months. Driving is permitted at 4–6 weeks when the patient can perform an emergency stop safely. Swimming is allowed at 4–6 weeks; gym exercise at 3 months. Solid bone fusion is confirmed radiographically (standing X-rays and CT scan) at 6–12 months. Maximum functional benefit is typically achieved at 12–24 months as the fusion matures and rehabilitation progresses.